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Abstract
Introduction: Primary pulmonary mucinous cystic neoplasia comprises a group of tumors, from
benign cystadenoma to mucinous cystadenocarcinoma.
Case presentation: We report a case of primary pulmonary mucinous cystadenocarcinoma in a
75-year-old woman who was found to have a right hilar mass on a routine chest X-ray. A
lobectomy was performed and the resection specimen revealed a multicystic mucinous tumor.
Microscopically, the tumor was composed of confluent mucin-filled cystic spaces lined by columnar
mucin-secreting cells which ranged from cytologically bland to moderately atypical with
'bronchioloalveolar pattern' invasion into the adjacent parenchyma. Immunohistochemically, tumor
cells were positive diffusely for Cytokeratin 7, and focally for Cytokeratin 20 and Thyroid
Transcription Factor-1.
Conclusion: This case highlights the continuous spectrum of pulmonary mucinous cystic neoplasia
from benign mucinous cystadenoma to malignant mucinous cystadenocarcinoma, and the probable
existence of a 'borderline' mucinous cystic tumor. Although molecular data are lacking to
substantiate progression from benign to malignant in these neoplasms, the importance of
recognizing the morphologic continuum lies in alerting pathologists to thoroughly examine
specimens to rule out invasive foci in tumors with 'borderline' morphology.
Introduction
Primary mucinous cystic tumors of the lung are rare neo-
plasms with a distinctly different histology from more
commonly encountered pulmonary adenocarcinomas.
Although these mucinous neoplasms are histologically
similar to well recognized mucinous tumors of the ovary,
pancreas and appendix, there has been considerable con-
fusion in the literature with the use of various diagnostic
terms, including some overlapping ones. These terms
include mucinous cyst, mucinous cystadenoma, muci-
nous multilocular cystic carcinoma, pseudomyxomatous
pulmonary adenocarcinoma, mucinous cystic tumor of
low malignant potential, mucinous cystic tumor of bor-
derline malignancy, mucinous cystadenocarcinoma, col-
loid carcinoma and signet ring cell carcinoma [1]. They
include diverse entities that span a spectrum of histologic
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changes and biologic behavior ranging from benign, to
borderline and malignant. Using strict diagnostic criteria,
pulmonary mucinous cystic neoplasia (PMCN) may be
recognized as a distinct entity [1]. Individual variation in
tumor behavior occurs, that is not well predicted by histo-
logic features. As a result, cases of 'borderline malignancy'
have been reported with recurrence or metastases. Con-
versely, cases reported with microscopic foci of 'carci-
noma' have been free of recurrence or metastases. This
case illustrates the spectrum of histologic appearances in
PMCN and the importance of recognizing them.
Case presentation
A 75-year-old woman with a 60-year history of tobacco
use was noted to have a right hilar mass on a routine chest
X-ray. Computed tomography (CT) scan and magnetic
resonance imaging (MRI) demonstrated a 4.5 cm well
defined mass with slightly lobulated margins present
between the upper and lower lobes of the right lung pos-
terior to the right hilum (Figure 1A). The mass abutted the
right main bronchus, the bronchus intermedius and the
medial pleural surface. Although the visual impression of
the mass radiologically suggested a solid mass, attenua-
tion within the mass (approximately 24 Hounsfield Units
(HU)) was less than in the aorta containing blood
(approximately 35 HU) and skeletal muscle (approxi-
mately 46 HU) indicative of a cystic rather than a solid
lesion (Figure 1A). There was no associated adenopathy or
obvious compression of the airway or other structures.
Positron emission tomography (PET) scan showed
increased uptake in the thyroid gland which on follow-up
ultrasound and fine-needle aspiration was diagnosed as
(A) Computed tomography scan shows a well-defined mass (white arrow) with slightly lobulated margins posterior to the right  hilum Figure 1
(A) Computed tomography scan shows a well-defined mass (white arrow) with slightly lobulated margins pos-
terior to the right hilum. The annotations show comparative attenuations within the mass (23.86 HU), aorta (35 HU) and 
skeletal muscle (46 HU), indicating a cystic lesion. (B) Gross photograph demonstrating a nodular cystic mass. (C) Gross pho-
tograph demonstrating translucent cystic appearance due to the abundant mucin content.
A
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multinodular colloid goiter and thyroiditis. Additional
work-up was negative for metastatic disease. The patient
was minimally symptomatic with a mild cough produc-
tive of yellow sputum, but with no shortness of breath or
evidence of hemoptysis. The pulmonary mass was felt to
represent a primary tumor and the patient underwent sub-
sequent thoracotomy with right upper lobectomy and seg-
mentectomy of the right lower lobe. At follow-up 2 years
later, she had no evidence of recurrence or metastatic dis-
ease.
On pathological examination, the specimen consisted of
resected right upper lobe of lung with attached superior
segment of right lower lobe. The pleural surface showed a
retracted, indurated area 4.5 × 3 cm close to the bronchus
intermedius of the upper lobe. On sectioning, a 5.5 cm
nodular cystic mass with a distinctly mucoid appearance
(Figure 1B and 1C) was seen.
Microscopically, the tumor, although situated adjacent,
did not have any relationship with the bronchus, was
well-demarcated from the surrounding lung, and had a
multicystic appearance without any distinct solid areas
(Figure 2A). The cysts contained abundant pale basophilic
mucin and the cyst lining showed a spectrum of appear-
ances. In some areas, the lining consisted of simple
columnar mucinous epithelium, with frequent goblet
cells. The nuclei were regular, basally oriented; without
stratification, atypia or mitoses (Figure 2B). In other areas,
there was significant tufting, stratification and hyperchro-
masia of nuclei coupled with pleomorphism and mitotic
activity (Figure 2C). At the periphery of the tumor, there
was evidence of invasion into surrounding parenchyma in
a 'lepidic/bronchioloalveolar' pattern. Mucinous tumor
cells appeared to line alveoli in a patchy fashion while
respecting the alveolar septal framework (Figure 2D).
Immunohistochemically, the tumor cells showed strong
positivity for Cytokeratin 7 (CK7) (Figure 3A). Cytokera-
tin 20 (CK20) was focally positive (Figure 3B). Thyroid
Transcription Factor-1 (TTF-1) and p53 were negative and
cell proliferation marker MIB-1 showed a low positivity
index (< 10%).
Discussion
Primary mucinous cystic tumors of the lung are very rare.
Following their initial description [2,3], approximately 76
cases have been reported in the English literature [1,4-10].
Clear-cut criteria for the diagnostic designation of PMCN
are lacking, partly owing to the different terminologies
that have been used to describe them [1]. For example, the
term 'mucinous or colloid' carcinoma has been used for
tumors morphologically resembling mucinous cystic
tumors [4,11]. However, PMCN deserve to be a separate
(A) Low power microphotograph demonstrating a multicystic tumor without any distinct solid areas, partially rimmed by a  fibrous capsule Figure 2
(A) Low power microphotograph demonstrating a multicystic tumor without any distinct solid areas, partially 
rimmed by a fibrous capsule. Hematoxylin and eosin, 4×. (B) Benign areas in the tumor consisting of a simple columnar 
mucinous epithelial lining, with frequent goblet cells. The nuclei are regular, basally oriented; without stratification, atypia or 
mitoses. Hematoxylin and eosin, 20×. (C) Areas of 'borderline' morphology with significant tufting, stratification and hyper-
chromasia of nuclei coupled with pleomorphism and mitotic activity. Hematoxylin and eosin, 20×. (D) Invasion into surround-
ing parenchyma in a 'lepidic/bronchioloalveolar' pattern. Mucinous tumor cells appear to line alveoli in a patchy fashion while 
respecting the alveolar septal framework. Hematoxylin and eosin, 40×.
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entity due to their unique morphology and clinical behav-
ior that is different from other primary lung tumors. In
line with this thinking, the World Health Organization
(WHO) classifies mucinous cystadenocarcinoma and col-
loid/mucinous carcinoma separately [12]. Mucinous cys-
tadenocarcinoma is 'a circumscribed tumor that may have
a partial fibrous capsule. Centrally there is cystic change
with mucin pooling and the neoplastic mucinous epithe-
lium grows along alveolar walls'. Mucinous (colloid) car-
cinoma, on the other hand, is described as a 'lesion
identical to their counterparts in the gastrointestinal tract,
with dissecting pools of mucin containing islands of neo-
plastic epithelium. The epithelium in such cases may be
extremely well differentiated and sometimes tumor cells
float within the pools of mucin'. Mucinous cystadenoma
is defined as 'a localized cystic mass filled with mucin and
surrounded by a fibrous wall lined by well-differentiated
columnar mucinous epithelium'.
In a recent review [1], diagnostic criteria of PMCN have
been proposed based on well-defined morphologic fea-
tures including: 1) solitary, well-circumscribed tumors
with a cystic gross appearance; 2) no evidence of carci-
noma in situ in the bronchial mucosa; 3) mucin compris-
ing greater than 90% of the tumor bulk; 4) neoplastic
epithelial cells are mucin-producing and are found lining
the fibrous wall or floating within mucin; and 5) no evi-
dence of another primary mucinous malignant neoplasm.
In this analysis, the presence of solid invasive areas and
marked cytologic atypia, including prominent nuclear
stratification, nuclear enlargement or high nuclear/cyto-
plasmic ratio, prominent nucleoli, and frequent mitoses,
indicated malignancy. However, histologic features may
not be very accurate in predicting progression. Three sep-
arate reports comprising five cases of mucinous cystaden-
ocarcinoma demonstrated no evidence of recurrence or
metastasis after a range of 1.5 to 6 years of follow-up [6-
8]. Also, in a series of 11 cases of 'borderline' mucinous
cystic tumors, all patients were alive and well after a mean
follow-up of 4.7 years, despite the presence of micro-
scopic foci of carcinoma in four cases [5]. Conversely, dis-
tant metastasis has been reported in a case of a
'multilocular mucous cyst' in which seeding of the parietal
pleura was noted at the time of surgery [3]. Additionally,
a case of local recurrence of a borderline mucinous cystic
tumor after limited resection has also been reported [13],
as has been a patient with late recurrence of mucinous cys-
tadenoma [14].
The variation in biologic behavior, especially in the 'bor-
derline' category, brings into question the necessity of
having such a category for diagnostic purposes. In fact, the
WHO classification does not recognize pulmonary bor-
derline mucinous cystic tumor/mucinous cystic tumor
with atypia as a distinct entity [12]. However, the border-
line category still has its uses as outlined below. First, rec-
ognition of borderline features within a tumor ensures
adequate sampling of the lesion by pathologists so that
histologically malignant foci are not missed. Secondly, cli-
nicians are alerted to the need for close follow-up in such
cases. Therefore, until molecular genetic lesions underly-
ing this group of tumors are elucidated, borderline muci-
nous tumor should not be eliminated as a diagnostic
category. In the current case, the existence of the full spec-
trum of benign, borderline and malignant histology
within a single tumor suggests that these tumors may be
analogous to type I ovarian tumors according to the
model proposed by Shih and Kurman [15].
The differential diagnosis of PMCN includes mucous
gland adenoma, mucoepidermoid carcinoma, mucinous
bronchioloalveolar carcinoma and metastatic mucinous
carcinoma. Mucous gland adenoma and mucoepider-
moid carcinoma are both endobronchial lesions in con-
trast to the peripheral location of PMCN. Mucous gland
adenoma exhibits cystically dilated mucin glands protrud-
ing into the bronchial lumen while mucoepidermoid car-
cinoma is composed of mucin-producing cells admixed
with squamous and intermediate cells [12]. A thorough
(A) Immunohistochemistry Figure 3
(A) Immunohistochemistry. CK7 positivity. (B) Immuno-
histochemistry. CK20 positivity.
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clinical and radiologic evaluation is necessary to exclude a
metastasis of mucinous carcinoma from another organ.
The immunohistochemical profile in the current case con-
sisted of strong diffuse positivity for CK7 and focal posi-
tivity for CK20, whereas TTF-1 was negative. Such an
immunoprofile may be a source for diagnostic confusion.
It is important to remember that CK20 positivity has been
described in some types of primary pulmonary mucinous
lesions [8]. Differentiating pulmonary mucinous cystade-
nocarcinoma from mucinous bronchioloalveolar carci-
noma may pose a challenge, especially in those unusual
cases where necrosis leads to secondary cavitation or cyst
formation in the latter. Necrosis is conspicuously absent
in mucinous cystadenocarcinoma. Growth pattern is
another differentiating feature. While PMCN are solitary,
generally well circumscribed tumors, mucinous bronchi-
oloalveolar carcinoma is diffuse and often bilateral,
appearing grossly as an ill-defined lobar consolidation.
The optimal management of PMCN appears to be com-
plete surgical excision by lobectomy. The role of adjuvant
therapy is unclear, but likely limited. In our patient, the
tumor was resected with clear margins and all 15 lymph
nodes submitted for histological examination were nega-
tive for metastasis. Although our patient's prognosis is
favorable, close long-term follow-up is clearly indicated.
Conclusion
In summary, we have reported a case of pulmonary muci-
nous cystadenocarcinoma which showed histologic
changes extending from the benign to the malignant end
of the spectrum. The pathologist's role in such cases lies in
recognizing the entity, distinguishing it from other muci-
nous lesions in the lung and alerting the clinician to the
probability of aggressive behavior in the presence of atyp-
ical 'borderline' histology and invasive foci.
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